PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1401796
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1401796
Single Cell Genome Sequencing Market size was valued at USD 3,300 Million in 2022, expanding at a CAGR of 16.8% from 2023 to 2030.
single-cell sequencing helps in clarifying the omics characteristics of every layer of genomic, epigenomic, and transcriptomic data. Single-cell sequencing is a next-generation sequencing (NGS) technique that offers a high-resolution analysis of individual cell genomes or transcriptomes. Multiple displacement amplification (MDA), cell lysis, and single-cell isolation from the ambient sample are all steps in the single-cell genome sequencing process.
Single Cell Genome Sequencing Market- Market Dynamics
Increasing prevalence of chronic diseases like diabetes, cancer, and arthritis to propel market demand
The growing population of older adults, the use of cutting-edge technology and new partnerships, and the growing incidence of chronic illnesses including cancer, diabetes, and arthritis is driving the market growth. The remarkable technological developments in single-cell genome sequencing (SCGS) are having a substantial impact on market growth. As an example, Bio-Rad Laboratories, Inc. and Illumina, Inc. collaborated to develop a novel workflow for SCGS analysis. A state-of-the-art SCGS solution was introduced because of this successful collaboration. These cutting-edge platforms are a promising addition to the market because they provide affordable, intuitive analysis software solutions. Because of the advantages that the devices provide, increasing disease prevalence is also anticipated to stimulate medication development activities in the area, which will boost the market growth. For example, the September 2020 article "United States Tax Dollars Funded Every New Pharmaceutical in the Last Decade" cites 2.2 million published studies on biological drugs or targets, of which 21% mention have received funding over USD 230 billion from the National Institutes of Health (NIH).
Single Cell Genome Sequencing Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.8% over the forecast period (2023-2030)
Based on Product Type segmentation, instruments was predicted to show maximum market share in the year 2022, owing to rising product development and technology solutions.
Based on Technology segmentation, PCR was the leading segment in 2022, mainly due to rise in R&D activities.
Based on Application segmentation, circulating cells was the leading segment in 2022, mainly due to increase in circulating tumor cells.
Based on End user segmentation, academic & research laboratories was the leading type in 2022, mainly due to rising research in genome related functions.
On the basis of region, North America was the leading revenue generator in 2022, owing to growing adoption technological products.
The Global Single Cell Genome Sequencing Market is segmented on the basis of Product Type, Technology, End-User, and Region.
The market is divided into two categories based on Product Type: instruments and reagents. The instruments dominate the market. The growing accelerated development and adoption of latest instruments is expected to boost the segment growth.
The market is divided into five categories based on Technology: NGS, PCR, qPCR, Microarray, and MDA. The PCR dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to recent COVID-19 crisis and respiratory disease concerns.
The market is divided into five categories based on Application: circulating cells, cell differentiation/reprogramming, genomic variation, subpopulation characterization, and others. The circulating cells dominates the market and is likely to maintain its dominance during the forecast period. This is due to rising clinical application in circulation tumor cells.
The market is divided into four categories based on End User: academic & research laboratories, biotechnology & biopharmaceutical companies, clinics, and others. The academic & research laboratories dominate the market and is likely to maintain its dominance during the forecast period. This is partly due to an increasing number of research in genome centers.
Single Cell Genome Sequencing Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Major players in the market aim to advance in order to become the industry leaders. Additionally, firms are introducing state-of-the-art technology breakthroughs into the market and actively extending their research and development projects. The market is undergoing several events, including new launches, acquisitions, and the application of competitive tactics. Additionally, the participants' strategic cooperation to fortify the opposition globally. As an example, in October 2021, PerkinElmer and Honeycomb Biotechnologies announced the introduction of the first-ever HIVE scRNAseq Solution, designed for single-cell isolation and analysis.
In October 2022, Oxford Nanopore Technologies PLC announced a partnership with 10x Genomics, aimed at streamlining the workflow to enable the sequencing of full-length transcripts in single reads.
The scope of this report covers the market by its major segments, which include as follows: